期刊文献+

糖尿病增加肝硬化患者发生肝性脑病风险的临床研究 被引量:4

Diabetes Mellitus is Associated with Hepatic Encephalopathy in Patients with Cirrhosis
原文传递
导出
摘要 目的观察糖尿病(DM)对肝硬化患者发生肝性脑病(HE)风险的影响。方法回顾性比较肝硬化合并DM与未合并DM的患者HE发病率及严重程度的差异,分析糖化血红蛋白(GHb)水平与HE发病率及严重程度的关系。结果在197例肝硬化患者中,DM患病率为21.8%;HE在肝硬化合并DM组的患病率为83.7%,显著高于不合并DM组的37.7%(P<0.05);在DM组中,GHb≥8%亚组中HE患病率为91.3%,显著高于GHb<8%亚组的75.0%(P<0.05);Ⅲ、Ⅳ期HE患者占DM组HE患者的61.1%,显著高于不合并DM组的32.8%(P<0.05);Ⅲ、Ⅳ期HE患者占DM并GHb≥8%亚组HE患者的76.2%,显著高于DM并GHb<8%亚组的40.0%(P<0.05)。结论肝硬化和DM可能存在伴随关系,DM可能增加肝硬化患者发生HE的风险。积极控制血糖可能有助于降低肝硬化患者HE的发病率,提高肝硬化患者的生存率。 Objective To investigate whether diabetes mellitus (DM) was associated with the incidence of hepatic encephalopathy(HE) in patients with liver cirrhosis. Methods By retrospectively analysis of 197 patients with liver cirrhosis, we studied the incidence and severity of HE in patients with or without DM, and in DM patients with glycolated hemoglobn (GHb) above 8% or below 8%. Results In this study,21.8% patients had HE;the incidence of HE in patients with DM was higher than that patients without DM(83.7% vs 37.7%, P 〈 0. 05 ). In the patients with DM, patients with serum GHb≥ 8% have higher incidence of HE than patients with serum GHb 〈8% (91.3% vs 75.0% , P 〈0.05). Severity of HE was also greater in DM group than in non-diabetic group(61.1% vs 32.8% , P 〈0.05) and in patients with serum GHb≥8% in patients than serum GHb 〈 8% ( 76.2% vs 40.0%, P 〈 0.05 ). Conclusion DM may be associated with liver cirrhosis and may increase the incidence of HE in patients with liver cirrhosis. Therefore, early blood glucose intervention may decrease the risk and mortality of HE in patients with liver cirrhosis.
出处 《临床消化病杂志》 2009年第3期156-158,共3页 Chinese Journal of Clinical Gastroenterology
关键词 肝硬化 肝性脑病 糖尿病 Cirrhosis Hepatic encephalopathy Diabetes mellitus
  • 相关文献

参考文献17

  • 1ARGUEDAS MR,DELAWRENCE TG,MCGUIRE BM.Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis[J].Dig Dis Sci,2003,48:1622.
  • 2BUSTAMANTE J,RIMOLA A,VENTURA PJ,et al.Prognostic significance of hepatic eneephalopathy in patients with cirrhosis[J].J Hepatol,2999,30:890.
  • 3CARACENI P,VAN THIEL DH.Acute liver faihre[J].Lancet,1995,345:163.
  • 4Report of the export committee on the diagnosis and classification of diabetes mellitus[J].Diabetes Care,1997,20:1183.
  • 5FERENCI P,LOCKWOOD A,MULLEN K,et al.Hepatic encephalopathy-definition,nomenclature,diagnosis,and quantification:final report of the working party at the 11 th world congresses of gastroenterology[J].Vienna,1998.Hepatology,2002,35:716.
  • 6KWON SY,KIM SS,KWON OS,et al.Prognostic significance of glycaemic control in patients with HBV and HCV-related cirrhosis and diabetes mellitus[J].Diabet Med,2005,22:1530.
  • 7MERLI M,LEONETTI F,RIGGIO O,et al.Glucose intolerance and insulin resistance in cirrhosis are normalized after liver transplantation[J].Hepatology,1999,30:649.
  • 8RUBBIA-BRANDT L,FABRIS P,PAGANIN S,et al.Steatosis affects chronic hepatitis C progression in a genotype specific way[J].Gut,2004,53:406.
  • 9CLARK JM,DIEHI AM.Nonalcoholic fatty liver disease:an underrecogized cause of cryptogenic cirrhosis[J].JAMA,2003,289:3000.
  • 10BLEI AT,CORDOBA J.Subclinical encephalopathy[J].Dig Dis,1996,14(Suppl 1):2.

同被引文献46

引证文献4

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部